The ReSPonD trial - rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen

Emily J Henderson, Stephen R Lord, Jacqueline Ct Close, Andrew D Lawrence, Alan Whone, Yoav Ben-Shlomo

Research output: Contribution to journalArticle (Academic Journal)peer-review

18 Citations (Scopus)

Fingerprint Dive into the research topics of 'The ReSPonD trial - rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen'. Together they form a unique fingerprint.

Medicine & Life Sciences